Hims & Hers is shutting down the dermatology ... including treatments for hair loss, erectile dysfunction, and mental health, said shuttering Apostrophe would help it centralize its skincare ...

Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...

Hims & Hers Health (NYSE ... including treating sensitive areas such as erectile dysfunction and hair loss. And by expanding its offerings, it has reached a broader group of customers.

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% during that stretch. By focusing on offering customers personalized ...

Hims & Hers had been relying on offering a compounded ... including treating sensitive areas such as erectile dysfunction and hair loss. And by expanding its offerings, it has reached a broader ...

Hims Topical Finasteride & Minoxidil Spray ... But many people have found success with over-the-counter hair thickening products or with prescription medications like minoxidil and finasteride.

March 7 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being ...

Shares of Hims & Hers Health (HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its GLP-1 weight-loss drug Wegovy by more than half. The move obliterates ...

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading ...